183 related articles for article (PubMed ID: 29285747)
1. Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition.
Chen XL; Lei L; Hong LL; Ling ZQ
Histol Histopathol; 2018 Jul; 33(7):655-663. PubMed ID: 29285747
[TBL] [Abstract][Full Text] [Related]
2. NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence
Ding M; Bu X; Li Z; Xu H; Feng L; Hu J; Wei X; Gao J; Tao Y; Cai B; Liu Y; Qu X; Shen L
Int J Biol Sci; 2020; 16(16):3100-3115. PubMed ID: 33162818
[No Abstract] [Full Text] [Related]
3. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
4. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
Kim MJ; Lim J; Yang Y; Lee MS; Lim JS
Cancer Lett; 2014 Nov; 354(1):33-42. PubMed ID: 25153349
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers.
Hu W; Yang Y; Fan C; Ma Z; Deng C; Li T; Lv J; Yao W; Gao J
Apoptosis; 2016 Jun; 21(6):675-82. PubMed ID: 27113371
[TBL] [Abstract][Full Text] [Related]
7. Catabolic metabolism during cancer EMT.
Cha YH; Yook JI; Kim HS; Kim NH
Arch Pharm Res; 2015 Mar; 38(3):313-20. PubMed ID: 25634102
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.
Sciacovelli M; Frezza C
FEBS J; 2017 Oct; 284(19):3132-3144. PubMed ID: 28444969
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation.
Li L; Li W
Pharmacol Ther; 2015 Jun; 150():33-46. PubMed ID: 25595324
[TBL] [Abstract][Full Text] [Related]
10. Role of Metabolic Reprogramming in Epithelial⁻Mesenchymal Transition (EMT).
Kang H; Kim H; Lee S; Youn H; Youn B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027222
[TBL] [Abstract][Full Text] [Related]
11. The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer.
Chen X; Bode AM; Dong Z; Cao Y
FASEB J; 2016 Sep; 30(9):3001-10. PubMed ID: 27279361
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis.
Zhou S; Tang X; Tang F
Tumour Biol; 2016 Feb; 37(2):1505-13. PubMed ID: 26662959
[TBL] [Abstract][Full Text] [Related]
13. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
Ye X; Weinberg RA
Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype.
Cervantes-Arias A; Pang LY; Argyle DJ
Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947
[TBL] [Abstract][Full Text] [Related]
17. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition.
Stacy AJ; Craig MP; Sakaram S; Kadakia M
Oncotarget; 2017 Jan; 8(2):2114-2129. PubMed ID: 27924063
[TBL] [Abstract][Full Text] [Related]
19. NDRG2: a Myc-repressed gene involved in cancer and cell stress.
Yao L; Zhang J; Liu X
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):625-35. PubMed ID: 18604454
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancer.
Shen L; Qu X; Ma Y; Zheng J; Chu D; Liu B; Li X; Wang M; Xu C; Liu N; Yao L; Zhang J
Oncogenesis; 2014 Feb; 3(2):e86. PubMed ID: 24492480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
